HomeORY • BME
add
Oryzon Genomics SA
Previous close
€2.64
Day range
€2.63 - €2.67
Year range
€1.40 - €3.69
Market cap
211.84M EUR
Avg Volume
801.18K
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.76M | 7.32% |
Net income | -1.84M | -48.18% |
Net profit margin | — | — |
Earnings per share | -0.03 | -43.48% |
EBITDA | -3.72M | -7.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 64.75M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.84M | -48.18% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2000
Website
Employees
47
